Cleared Traditional

K113808 - THE SHERLOCK 3CG TIP CONFIRMATION SYSTE...

K113808 is the FDA 510(k) clearance for THE SHERLOCK 3CG TIP CONFIRMATION SYSTE... by C.R. Bard, Inc.. It is a Class 2 General Hospital device (product code LJS) cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K113808 · C.R. Bard, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2012
Decision
87d
Days
Class 2
Risk

K113808 is an FDA 510(k) clearance for the THE SHERLOCK 3CG TIP CONFIRMATION SYSTEM (TCS). Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Salt Lake Ciy,, US). The FDA issued a Cleared decision on March 19, 2012 after a review of 87 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K113808 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2011
Decision Date March 19, 2012
Days to Decision 87 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 129d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 116
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K113808.
MEDCOMP VASCU-PICC & MIDLINE CATHETERS
K121094 · Medical Components, Inc. · Jun 2012
1.9F X 20CM VASCU-PICC 1.9F X 50CM VASCU-PICC
K120980 · Medical Components, Inc. · May 2012
2.6F X 20CM VASCU-PICC 2.6F X 50CM VASCU-PICC
K120981 · Medical Components, Inc. · May 2012
SAPIENS TIP CONFIRMATION SYSTEM
K112744 · C.R. Bard, Inc. · Oct 2011
TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER (PICC)
K111244 · Cook, Inc. · Jun 2011
POWERPICC SV CATHETERS
K102159 · C.R. Bard, Inc. · Nov 2010